Trial intelligence / Profile preview

Vinpocetine in Acute Ischemic Stroke

NCT02878772Phase 3Completed

Sponsor
Tianjin Medical University General Hospital
Start
May 2014
Primary completion
Dec 2015
Modality
Small Molecules
01

Overview

A Phase 3 trial of vinpocetine in ischemic stroke, sponsored by Tianjin Medical University General Hospital. Started May 2014; status: completed.

02

Drugs

vinpocetine
03

Conditions

ischemic stroke

Beyond the preview

Go deeper on NCT02878772.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02878772.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call